**INTRODUCTION:** Assess the efficacy of Collagenase versus placebo in reducing the size of benign subcutaneous lipoma and assess the common short term side effects in a randomized, double-blind, placebo controlled study in subjects presenting with at least two benign lipomas of similar size.

**METHODS:** Collagenase derived from Clostridium Histolyticum was used in a randomized, double-blinded, placebo controlled study on a total of 19 healthy subjects, each with two biopsy-proven lipomas of similar size (one to receive drug and one to receive placebo) at two independent investigational centers (Office of Z. Gerut and Dept. of Plastic Surgery Vanderbilt Univ. Med Ctr.). An independent pharmacist prepared the research drug and the placebo for injection and the two indiscernible preparations were randomized for injection into the two lipomas of each subject; all staff including the investigators, as well as the subject were blinded.

**EXPERIENCE:** Patients were evaluated pre-injection and at day 1, 7, 14, 30, 90 and 180 post-injection. Efficacy was evaluated by MRI, caliper measurement and physical examination. All patients were tested for anti-Collagenase antibodies. All 19 patients that entered the study were followed to completion. There were no serious adverse events, no unsatisfactory therapeutic responses, no intercurrent medical problems. The visible surface area by caliper measurement of treated lipomas was reduced by an average of \>80% vs. +2% for placebo lipoma (p=0.0001) with 11 of 19 drug-treated lipomas becoming invisible on physical examination. MRI of drug-treated lipomas revealed \>50% decrease in lipoma volume while none of the placebo treated lipomas showed any significant diminution in size. In addition, one of the investigators has used Collagenase on human fat for contour modification.

**RESULTS:** By all employed metrics; MRI testing, caliper measurement, physical examination, the experimental drug showed significant efficacy in the treatment of lipoma. Many of the drug-treated lipomas clinically disappeared, all drug-treated lipomas showed significant diminution in size by both physical examination and MRI. All patients experienced some bruising and swelling; very few patients reported pain and in those cases, the pain was fleeting. There were no serious adverse events and none of the subjects were dissatisfied.

**CONCLUSION:** Collagenase is an effective treatment for treatment of lipoma as well as for the dissolution of human fat. The author has experience using the drug off label.
